1835F03
CAS No. 904579-65-3
1835F03( —— )
Catalog No. M16504 CAS No. 904579-65-3
1835F03 is a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1835F03
-
NoteResearch use only, not for human use.
-
Brief Description1835F03 is a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus.
-
Description1835F03 is a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number904579-65-3
-
Formula Weight415.896
-
Molecular FormulaC19H18ClN5O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name7-chloro-N,N-diethyl-3-(phenylsulfonyl)-[1,2,3]triazolo[1,5-a]quinazolin-5-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Swoboda JG, et al. ACS Chem Biol. 2009 Oct 16;4(10):875-83.
2. Lee K, et al. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1767-70.
3. Suzuki T, et al. Antimicrob Agents Chemother. 2011 Feb;55(2):767-74.
molnova catalog
related products
-
Ligustilide A
Ligustilide A, an active ingredient isolated from the medicinal plants Angelica acutiloba and Cnidium officinale, inhibits benzo(a)pyrene-induced CYP1A1 upregulation in cultured human keratinocytes via ROS-dependent Nrf2 activation.
-
Durlobactam
Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
-
Omadacycline
Omadacycline a new tetracycline antibiotic can inhibit the 30s subunit of bacterial ribosome.
Cart
sales@molnova.com